MedTrace Logo

Hospitalised Pneumonia With Extended Treatment (HOPE) Study

NCT02783859 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 314

Last updated 2026-01-15

No results posted yet for this study

Summary

An intervention study to determine if a longer duration of antibiotics (compared to shorter duration) improves the short and long term clinical outcomes of children hospitalised for pneumonia

Conditions

Interventions

DRUG

Amoxicillin-clavulanic Acid

DRUG

Placebo (for Amoxicillin-clavulanic Acid)

Sponsors & Collaborators

  • Griffith University

    collaborator OTHER

  • Sarawak General Hospital

    collaborator OTHER

  • University of Malaya

    collaborator OTHER

  • The University of Queensland

    collaborator OTHER

  • Queensland University of Technology

    collaborator OTHER

  • Nanyang Technological University

    collaborator OTHER

  • Menzies School of Health Research

    lead OTHER

Principal Investigators

  • Anne Chang, PhD · Menzies School of Health Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
3 Months
Max Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2022-06-30
Completion
2022-12-31

Countries

  • Australia
  • Malaysia
  • New Zealand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02783859 on ClinicalTrials.gov